Fibromyalgia

Fibromyalgia- Aptinyx NYX-2925-2005- A Randomized, Double-Blind, Placebo‑Controlled Study to Assess the Efficacy and Safety of NYX-2925 in Subjects with Fibromyalgia.

Study Information

Condition

Fibromyalgia

Phase

Conquest Research needs volunteers for an investigational trial evaluating a medication designed to help treat patients suffering from Fibromyalgia. You may qualify if you:

  • Must be between the ages of 18 and 75

  • Has a current diagnosis of Fibromyalgia

Eligible participants will receive study-related care at no cost. Compensation for time and travel may be available. No medical insurance is required for participation.

What To Expect

PATIENT RESOURCES & FAQ

Conquest Research is partnering with physician practices throughout Central Florida to raise awareness and offer clinical research opportunities to those in need.

A mature medical doctor smiling as some of his colleagues stand in the background

Register For A Study!